白癜风专家李从悠 https://m.sohu.com/a/330332735_120224920
胃肠道、肝胆胰肿瘤

食管肿瘤

1.Barrett’s食管

阳性:CK20,MUCs,CDX2,P53

2.鳞状细胞癌(普通型)

阳性:CAM5.2,AE1/AE3,CK5/6,34βE12,CK14,P63(部分),CK19

阴性:CK7,CK20,WT-1,CD5,TTF-1

3.基底细胞样鳞癌

阳性:Bcl-2,CK5/6,CK13,CK14,CK19,P63,S-

阴性:CAM5.2,AE1/AE3

4.腺癌

阳性:CK7,CK20

阴性:P63

5.腺样囊性癌

阳性:CAM5.2,AE1/AE3,CD

(导管分化细胞)34βE12,CEA

(肌上皮分化细胞)S-,SMA,vimentin,P63

阴性:CgA,Syn

6.黏液表皮样癌

阳性:(鳞状上皮样区域)34βE12,CK14,P63

(腺上皮区域)CK7,CEA

7.梭形细胞分化癌或肉瘤样癌

阳性:CAM5.2,AE1/AE3,vimentin

阴性:desmin

8.平滑肌瘤

阳性:SMA,desmin,MSA,calponin

阴性:CD34,CD,S-

9.平滑肌肉瘤

阳性:SMA,desmin,vimentin

阴性:CD34,CD

10.胃肠道间质瘤

阳性:CD34,CD,PDGFRA,DOG1,PKCθ

11.神经内分泌肿瘤

阳性:Syn,CgA,NSE,TTF-1,CD56

阴性:CK19,CK20,34βE12

12.横纹肌肉瘤

13.滑膜肉瘤

14.Kaposi肉瘤

阳性:CD31,CD34

15.颗粒细胞瘤

阳性:S-,CD57,vimentin

阴性:desmin,CD34,CD,CAM5.2,EMA,CEA

16.恶性黑色素瘤

阳性:vimentin,S-,HMB45,MART/melan-A,tyrosinase

阴性:CK,CEA

17.淋巴瘤(大B细胞淋巴瘤和MALT淋巴瘤多见)

胃部肿瘤

1.胃腺癌

阳性:CAM5.2,Pan-CK,CK7,CK20,CK18,CK19,CDX2,CEA(部分),villin(部分),Her-2

阴性:CK5/6,vimentin,P63(鳞化区域可阳性),TTF-1,CA(少量)

2.含神经内分泌分化的腺癌

阳性:CKs,CgA,Syn

阴性:CD56

3.印戒细胞癌

阳性:CDX2,CK20,CEA

阴性:GCDFP-15,ER

4.高分化神经内分泌肿瘤或小细胞癌

阳性:CgA,Syn,CDX2

阴性:CK20,TTF-1,CK5/6

5.肉瘤样癌

6.胃肠道间质瘤

阳性:CD,CD34,CD99,SMA,HHF-35(25%-50%),CK18(10%)

阴性:Syn(5%),desmin(2%),CgA,S-

7.神经鞘瘤

阳性:S-,CD57(Leu7),GFAP

阴性:CD,CD34,SMA

8.纤维瘤病

阳性:vimentin,desmin,β-catenin

阴性:CD,CD34(少量细胞可阳性)

9.孤立性纤维瘤

阳性:CD34,CD99,SMA,Bcl-2

阴性:CD

10.肝样腺癌

阳性:AFP,Hepatocyte

11.绒毛膜癌

阳性:β-hCG,PLAP

小肠肿瘤

1.神经内分泌肿瘤

阳性:CgA,Syn,CD57,villin,CEA,CDX2,CK20(25%),somatostatin

阴性:CK7,TTF-1

2.GIST

阳性:CD,CD34,Bcl-2,SMA,S-(20%)

阴性:desmin,CgA

3.远端小肠腺癌(表型类似结肠癌)

阳性:CK18,CK19,CK20,CDX2,villin,MUC1,MUC5AC(33%)

阴性:CK7,CK5/6,P63,vimentin

4.壶腹部腺癌(表型类似胰胆管腺癌)

阳性:CK18,CK19,CK7(50%),CK20(50%),CDX2,MUC1,MUC5AC(33%)

阴性:CK5/6,P63,vimentin

阑尾肿瘤

1.神经内分泌肿瘤

阳性:CgA,Syn,E-cadherin,β-catenin,CK20,CDX2

阴性:CEA,CK7

2.不产生黏液的腺瘤及腺癌

阳性:CK20,CK7

3.产生黏液的腺瘤及腺癌

阳性:CK8,CK18,CK19,CK20,CDX2,villin,MUC2,MUC5A,MUC1(20%)

结直肠肿瘤

1.神经鞘瘤

阳性:S-,GFAP,CD34

阴性:CD

2.神经纤维瘤

阳性:S-,neurofilament

阴性:CD

3.GIST

阳性:CD,CD34,CD99,SMA

阴性:GFAP,desmin,S-,neurofilament

4.平滑肌瘤

阳性:SMA,MSA,desmin

阴性:CD,CD34,S-

5.神经内分泌肿瘤

(右半结肠)阳性:serotonin,CgA,Syn,CK20(50%),CK7(25%)

阴性:S-,TTF-1

(直乙结肠)阳性:CgA,Syn,PAP(少数)

阴性:S-,PSA,PS

6.腺癌

阳性:CK20,CDX2,villin,MUC1,MUC2,S-(20%),PLAP(部分,膜阳性),CA

阴性:CK7(5%可阳性),CgA,Syn,MUC5A,CK5/6,GCDF-15,TTF-1,HPC

7.高分化神经内分泌肿瘤

阳性:Syn,低分子量CK,CAM5.2,35βH11(含有非角化鳞癌成分)34βE12,CK5/6,P63

阴性:CK20,CgA,CD57,CD

8.肉瘤样癌

肛管肿瘤

1.鳞状细胞癌及其亚型

2.腺癌

阳性:CK7

阴性:CK20

3.Paget’s病

阳性:AE1/AE3,CK7,CK20(部分),CEA,GCDFP-15

阴性:34βE12,S-

胰腺肿瘤

1.胰腺神经内分泌肿瘤

阳性:PGP9.5,CgA,Syn,CK8,CK18,CAM5.2,AE1/AE3(部分)

阴性:CK7,CK20,TTF-1,CDX2,HepPar1,Villin

2.低分化神经内分泌癌

阳性:CD56,CD57,CgA,Syn,calcitonin

3.导管内乳头状黏液性肿瘤

阳性:CK7,CDX2,MUC2,MUC5AC,DUPAN-2,CA19-9,hMLH1,hMLH2,hMLH6

阴性:CK20,CEA

4.黏液性囊性肿瘤

阳性:CK7,CK20,CA,CA19-9,MUC5A,Smad4

(卵巢样间质区域)vimentin,SMA,MSA,ER(20%-80%),α-inhibin

阴性:MUC1,MUC2

5.浆液性囊腺瘤

阳性:AE1/AE3,EMA,MUC1,MUC6,CA19-9

阴性:CEA,CgA,Syn

6.导管腺癌

阳性:EMA,CAM5.2,CA19-9,CK19,CK7,CK20,MUC1,MUC4,MUC5A,CDX2,Smad4,CD5,CD7,mesothelin

部分阳性:CgA,Syn,CA,villin,CK5/6

阴性:AFP,PAP,PSA,WT-1,TTF-1,MUC2,HPC,vimentin,ER,PR

7.浸润性黏液性腺癌

阳性:MUC2

阴性:CA,MUC1

8.含破骨样巨细胞的未分化癌

阳性:pan-CK,vimentin,AE1/AE3,CAM5.2,35βH11,CK8,CK18,CK19

(破骨样巨细胞)CD68,LCA,CD71,α-1-antichymotrypsin

阴性:EMA,CEA,HMB45,MART-1

9.腺泡细胞癌

阳性:AE1/AE3,CAM5.2,CK7,CK8,CK19,trypsin,α-1-antichymotrypsin,Syn(10%-50%)

阴性:CEA,CgA,vimentin,AFP

10.实性假乳头状瘤

阳性:α-1-antichymotrypsin,vimentin,β-catenin

(部分表达)CK20,AE1/AE3,CAM5.2,CK7,CD10,Syn,ER,PR

阴性:EMA,CEA,AFP,CA19-9,S-

11.血管周上皮样细胞瘤

阳性:actin,HMB45,Myo-D1

阴性:CD,CD34,SMA,AE1/AE3,CAM5.2,CgA,Syn

肝及胆管肿瘤

1.胆汁性肝硬化及硬化性胆管炎

阳性:(小胆管上皮)CK7,CK19,CD31/CD34

2.肝细胞腺瘤

阳性:CK8,CK18,HPC

阴性:CK7,CK19,CK20,CA19-9,34βE12

3.胆管错构瘤及腺瘤

阳性:CK7,CK19

阴性:CK20,MUC1,CEA

4.肝母细胞瘤

阳性:AFP,CgA,CKs,vimentin

5.普通型肝细胞癌

阳性:CK8,CK18,CAM5.2,OSCAR,AFP(高级别肝细胞癌阴性),HPC,AE1/AE3(少数),CD56(弱),CD31/34(内皮细胞),EMA,CEA(胆管型)

阴性:CK7(少数阳性),CK20(20%阳性),CK17,CA19-9,Calretinin,α-inhibin,TTF-1,CgA,Syn,MART-1,CK5/6,ER

6.具有胆管分化的肝细胞癌

阳性:AE1/AE3,CK7,CK19,CEA

7.梭形细胞肝细胞癌

阳性:vimentin,CAM5.2,HPC

阴性:AFP

8.纤维板层型肝细胞癌

阳性:CK8,CK18,CAM5.2,HPC,CK7,AFP(20%),α-1-antichymotrypsin

9.胆管癌

阳性:CK7,CK8,CK18,CK19,CAM5.2,CA19-9,CEA,MOC-31,CDX2(75%),CK17(50%),CK20(20%)

阴性:HPC,AFP,Syn,GCDFP-15

10.梭形细胞胆管癌或肉瘤样癌

阳性:vimentin,CEA,低分子量角蛋白(CAM5.2,AE1/AE3,EMA)

阴性:AFP,S-

11.混合性肝细胞-胆管癌

12.低分化/未分化癌

阳性:CK7,CK19

阴性:CEA,CA19-9,AFP,HPC

13.胆管囊腺瘤或癌

阳性:AE1/AE3,CA19-9,CEA,CK7,CK20,CA,vimentin,SMA,desmin

14.神经内分泌肿瘤(低级别及高级别)

推荐阅读

肺癌,精准医疗系列文章

肺癌,临床试验招募汇总

NCCN丨非小细胞肺癌临床实践指南.6版①

NCCN丨非小细胞肺癌临床实践指南.6版②

NCCN丨小细胞肺癌临床实践指南.3版

NCCN丨免疫治疗相关毒性的管理指南.1版①

NCCN丨免疫治疗相关毒性的管理指南.1版②

NCCN丨癌症相关感染的预防和治疗指南.2版①

NCCN丨癌症相关感染的预防和治疗指南.2版②

NCCN丨止吐临床实践指南.2版

NCCN丨造血生长因子临床实践指南.2版

NCCN丨成人癌痛临床实践指南.1版①

NCCN丨成人癌痛临床实践指南.1版②

加,方便免费咨询和寻找最合适的免费治疗项目

预览时标签不可点收录于话题#个上一篇下一篇

转载请注明:http://www.aoakn.com//mjccby/14681.html
------分隔线----------------------------